HDL subclasses and mortality in acute heart failure patients

Area of Science:

• Cardiology
• Biochemistry
• Prognostics

Background:

• The prognostic role of high-density lipoprotein (HDL) subclasses in cardiovascular diseases is debated.
• Acute heart failure (AHF) presents significant mortality risks.

Purpose of the Study:

• To investigate the prognostic value of HDL subclasses (HDL3-C, HDL2-C) and total HDL-C for 3-month mortality in AHF patients.

Main Methods:

• Serum levels of HDL3-C and total HDL-C were measured using a homogeneous assay.
• HDL2-C was calculated as the difference between total HDL-C and HDL3-C.
• Logistic regression analyses were performed to assess associations with 3-month mortality.

Main Results:

• A significant inverse association was found between HDL3-C and 3-month mortality (univariate OR 0.46, adjusted OR 0.34).
• Total HDL-C and HDL2-C showed no significant association with mortality.
• Low admission HDL3-C levels were linked to increased mortality risk in AHF patients.

Conclusions:

• HDL3-C, but not total HDL-C or HDL2-C, is a significant independent predictor of 3-month mortality in AHF.
• HDL3-C may be a valuable prognostic biomarker for patients with acute heart failure.